Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference
Illumina (NASDAQ: ILMN) has announced a live webcast of its upcoming investor session at the Advances in Genome Biology and Technology (AGBT) Conference. The investor fireside chat is scheduled for Tuesday, February 25, 2025, at 8:00am PT (11:00am ET).
The session will feature presentations from key executives including Jacob Thaysen (CEO), Ankur Dhingra (CFO), and Steve Barnard (CTO). Investors, analysts, and interested parties can access the webcast through Illumina's website Investor Info section or via the provided direct link.
Participants are advised to join ten minutes before the scheduled start time to ensure proper connection. A replay of the session will be available on Illumina's website for at least 30 days after the event.
Illumina (NASDAQ: ILMN) ha annunciato una diretta streaming della sua prossima sessione per investitori al Conference Advances in Genome Biology and Technology (AGBT). Il colloquio con gli investitori è programmato per martedì 25 febbraio 2025, alle 8:00 PT (11:00 ET).
La sessione includerà presentazioni da parte di dirigenti chiave, tra cui Jacob Thaysen (CEO), Ankur Dhingra (CFO) e Steve Barnard (CTO). Investitori, analisti e parti interessate possono accedere alla diretta streaming attraverso la sezione Informazioni per Investitori sul sito di Illumina o tramite il link diretto fornito.
Si consiglia ai partecipanti di unirsi dieci minuti prima dell'orario di inizio programmato per garantire una connessione adeguata. Una registrazione della sessione sarà disponibile sul sito di Illumina per almeno 30 giorni dopo l'evento.
Illumina (NASDAQ: ILMN) ha anunciado una transmisión en vivo de su próxima sesión para inversores en la Conferencia de Avances en Biología y Tecnología del Genoma (AGBT). La charla con los inversores está programada para el martes 25 de febrero de 2025, a las 8:00 a.m. PT (11:00 a.m. ET).
La sesión contará con presentaciones de ejecutivos clave, incluyendo a Jacob Thaysen (CEO), Ankur Dhingra (CFO) y Steve Barnard (CTO). Los inversores, analistas y partes interesadas pueden acceder a la transmisión a través de la sección de Información para Inversores del sitio web de Illumina o mediante el enlace directo proporcionado.
Se aconseja a los participantes unirse diez minutos antes de la hora de inicio programada para asegurar una conexión adecuada. Una grabación de la sesión estará disponible en el sitio web de Illumina durante al menos 30 días después del evento.
Illumina (NASDAQ: ILMN)는 유전체 생물학 및 기술의 발전 회의(AGBT)에서 있을 투자자 세션의 라이브 웹캐스트를 발표했습니다. 투자자 간담회는 2025년 2월 25일 화요일 오전 8시 PT (오후 11시 ET)로 예정되어 있습니다.
세션에는 Jacob Thaysen (CEO), Ankur Dhingra (CFO), Steve Barnard (CTO)와 같은 주요 경영진의 발표가 있을 예정입니다. 투자자, 분석가 및 관심 있는 분들은 Illumina 웹사이트의 투자자 정보 섹션 또는 제공된 직접 링크를 통해 웹캐스트에 접근할 수 있습니다.
참가자들은 적절한 연결을 보장하기 위해 예정된 시작 시간 10분 전에 참여할 것을 권장합니다. 세션의 재생은 이벤트 후 최소 30일 동안 Illumina 웹사이트에서 제공될 것입니다.
Illumina (NASDAQ: ILMN) a annoncé une diffusion en direct de sa prochaine session pour investisseurs lors de la Conférence sur les Avancées en Biologie et Technologie du Génome (AGBT). La discussion avec les investisseurs est prévue pour mardi 25 février 2025, à 8h00 PT (11h00 ET).
La session comprendra des présentations de dirigeants clés, y compris Jacob Thaysen (PDG), Ankur Dhingra (CFO) et Steve Barnard (CTO). Les investisseurs, analystes et parties intéressées peuvent accéder à la diffusion via la section Informations pour Investisseurs du site Web d'Illumina ou via le lien direct fourni.
Il est conseillé aux participants de se connecter dix minutes avant l'heure de début prévue pour garantir une connexion adéquate. Un enregistrement de la session sera disponible sur le site d'Illumina pendant au moins 30 jours après l'événement.
Illumina (NASDAQ: ILMN) hat eine Live-Übertragung seiner bevorstehenden Investoren-Sitzung auf der Konferenz für Fortschritte in der Genomik und Technologie (AGBT) angekündigt. Das Gespräch mit den Investoren ist für Dienstag, den 25. Februar 2025, um 8:00 Uhr PT (11:00 Uhr ET) geplant.
Die Sitzung wird Präsentationen von Schlüsselpersonen beinhalten, darunter Jacob Thaysen (CEO), Ankur Dhingra (CFO) und Steve Barnard (CTO). Investoren, Analysten und Interessierte können über die Rubrik Investoreninformationen auf der Website von Illumina oder über den bereitgestellten direkten Link auf die Übertragung zugreifen.
Teilnehmer werden gebeten, zehn Minuten vor dem geplanten Beginn beizutreten, um eine ordnungsgemäße Verbindung sicherzustellen. Eine Aufzeichnung der Sitzung wird für mindestens 30 Tage nach der Veranstaltung auf der Website von Illumina verfügbar sein.
- None.
- None.
The investor fireside chat will begin at 8:00am Pacific Time (11:00am Eastern Time) on Tuesday, February 25, 2025 and will feature Jacob Thaysen (Chief Executive Officer), Ankur Dhingra (Chief Financial Officer), and Steve Barnard (Chief Technology Officer).
Interested parties may access the live webcast via the Investor Info section of Illumina's website or directly through the following link – (https://illumina-agbt-investor-session-feb-2025.open-exchange.net/) To ensure timely connection, please join at least ten minutes before the scheduled start of the session.
A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube.
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
Bonny Fowler
+1.740.641.5579
pr@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-session-at-the-advances-in-genome-biology-and-technology-agbt-conference-302379336.html
SOURCE Illumina, Inc.
FAQ
When is Illumina's (ILMN) AGBT investor session scheduled for 2025?
Which executives will present at Illumina's (ILMN) 2025 AGBT investor session?
How can investors access Illumina's (ILMN) AGBT conference webcast?
How long will the replay of Illumina's (ILMN) 2025 AGBT investor session be available?
What format will Illumina's (ILMN) AGBT investor presentation take?
